Conclusion In conclusion, compared with placebo or other interventions, GLP-1 receptor agonists did not increase or decrease the risk of thyroid cancer, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass and goiter
American College of Clinical Pharmacy
Dispose of used needles according to facility safety protocols immediately
Tuersun A, Hou G, Cheng G (2024) Efficacy and safety of the combination or monotherapy with GLP-1 receptor agonists and SGLT-2 inhibitors in Type 2 diabetes mellitus: an update systematic review and meta-analysis
Most GLP-1 medications are given as injections under the skin using a pen device with a very small needle
If your body is undertrained, weak, or chronically dysregulated, paying closer attention to it does not resolve that conditionit sharpens your awareness of it